These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 62383)

  • 1. Orcein positive hepatocellular material in long-standing biliary diseases. II. Ultrastructural studies.
    Sipponen P
    Scand J Gastroenterol; 1976; 11(6):553-7. PubMed ID: 62383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orcein positive hepatocellular material in histological diagnosis of primary biliary cirrhosis.
    Sipponen P; Salaspuro MP; Makkonen HM
    Ann Clin Res; 1975 Aug; 7(4):273-7. PubMed ID: 56154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological characteristics of chronic hepatides and primary biliary cirrhosis with special reference to orcein positive hepatocellular accumulations.
    Sipponen P; Salaspuro MP; Makkonen H
    Ann Clin Res; 1976 Jun; 8(3):200-5. PubMed ID: 63264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The occurrence of orcein-positive hepatocellular material in various liver diseases.
    Salaspuro MP; Sipponen P; Makkonen H
    Scand J Gastroenterol; 1976; 11(7):677-81. PubMed ID: 63138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orcein positive hepatocellular material in long-standing biliary diseases. I. Histochemical characteristics.
    Sipponen P
    Scand J Gastroenterol; 1976; 11(6):545-52. PubMed ID: 62382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical correlations and significance of orceinpositivity in chronic active hepatitis and primary biliary cirrhosis.
    Salaspuro MP; Sipponen P; Ikkala E; Kolho L; Makkonen HM; Miettinen TA; Räsänen JA; Siurala M
    Ann Clin Res; 1976 Jun; 8(3):206-15. PubMed ID: 63265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protein-copper complex in primary biliary cirrhosis and other chronic diffuse diseases of the liver].
    Loginov AS; Aruin LI; Shepeleva SD
    Arkh Patol; 1980; 42(4):50-5. PubMed ID: 7396755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of bile ducts in primary biliary cirrhosis and other liver diseases by immunohistochemical demonstration of Lewis(a) or b antigen.
    Fritz P; Pedal I; Oeffinger B; Tuczek HV; Wagner T; Rühl U; Romen A; Bader H
    Zentralbl Pathol; 1994 Nov; 140(4-5):299-307. PubMed ID: 7826978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of an intracellular copper-binding protein by orcein staining in long-standing cholestatic liver diseases.
    Salaspuro M; Sipponen P
    Gut; 1976 Oct; 17(10):787-90. PubMed ID: 63413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and pathological analysis on characteristics of primary biliary cirrhosis].
    Zhou GD; Zhao JM; Wang SS; Sun YL; Meng EH; Zhang TH; Liu P
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):483-6. PubMed ID: 12939182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron and copper deposition in chronic active hepatitis and liver cirrhosis; pathogenetic role in progressive liver cell damage.
    Ishida M; Nakagawara G; Imamura Y; Fukuda M
    Eur J Histochem; 1995; 39(3):221-36. PubMed ID: 8630440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical diagnosis of primary biliary cirrhosis: a classification based on major and minor criteria.
    Taal BG; Schalm SW; ten Kate FW; Hermans J; Geertzen RG; Feltkamp BE
    Hepatogastroenterology; 1983 Oct; 30(5):178-82. PubMed ID: 6642402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivesicular stellate cells in primary biliary cirrhosis.
    Cameron RG; Neuman MG; Shear N; Blendis LM
    Hepatology; 1997 Oct; 26(4):819-22. PubMed ID: 9328298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential findings for CD14-positive hepatic monocytes/macrophages in primary biliary cirrhosis, chronic hepatitis C and nonalcoholic steatohepatitis.
    Leicester KL; Olynyk JK; Brunt EM; Britton RS; Bacon BR
    Liver Int; 2006 Jun; 26(5):559-65. PubMed ID: 16762000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased portal tract infiltration of mast cells and eosinophils in primary biliary cirrhosis.
    Nakamura A; Yamazaki K; Suzuki K; Sato S
    Am J Gastroenterol; 1997 Dec; 92(12):2245-9. PubMed ID: 9399763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis.
    Jaffe CJ; Vierling JM; Jones EA; Lawley TJ; Frank MM
    J Clin Invest; 1978 Nov; 62(5):1069-77. PubMed ID: 711852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis.
    Harada K; Ozaki S; Gershwin ME; Nakanuma Y
    Hepatology; 1997 Dec; 26(6):1399-405. PubMed ID: 9397977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatocytic copper and copper-binding protein in primary biliary cirrhosis. Discrimination from chronic active hepatitis by means of orcein and rubeanic acid techniques.
    Lesna M; Hamlyn AN; Watson AJ
    Digestion; 1981; 22(3):113-8. PubMed ID: 7286461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the pathomorphology of primary biliary cirrhosis of the liver (author's transl)].
    Loginov AS; Aruin LI; Sepeleva SD
    Dtsch Z Verdau Stoffwechselkr; 1981; 41(6):261-9. PubMed ID: 7341218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.